Archive · 15 Jan 2026
Promoters Buying Shares in Four Indian Companies
Some company owners in India are buying more shares of their own companies.
This is happening even though the stock market has been up and down.
Four companies where this is happening are Enviro Infra Engineers, Indo Farm Equipments, Senores Pharma, and Suraksha Diagnostic.
Enviro Infra Engineers works on water and wastewater projects and has grown quickly.
Indo Farm Equipments makes tractors and cranes.
Senores Pharma sells medicines in many countries.
Suraksha Diagnostic runs labs and offers medical tests.
The owners of these companies are buying more shares because they believe their companies will do well in the future.
However, investors should also look at other things like how the company is run and its finances before deciding to invest.
Promoters of Enviro Infra Engineers increased their stake to 70.13%, with the company showing strong growth in sales and net profit.
Indo Farm Equipments' promoters raised their stake to 69.53%, with the company focusing on tractors and cranes.
Senores Pharma's promoters increased their stake to 45.8%, with the company experiencing exceptional growth in sales and net profit.
Suraksha Diagnostic's promoters raised their stake to 48.98%, with the company expanding through acquisitions and partnerships.
Promoter buying signals confidence in long-term prospects, but investors should also assess fundamentals and market conditions.
- Who
- Promoters of Enviro Infra Engineers, Indo Farm Equipments, Senores Pharma, and Suraksha Diagnostic
- What
- Promoters are buying shares in their own companies, signaling confidence in long-term prospects
- When
- During the December 2025 quarter
- Where
- India
- Why
- To reflect confidence in their businesses and back the upside they believe the market has yet to fully recognize
- Enviro Infra Engineers
- Specializes in water and wastewater management, 70.13% promoter stake, 62% sales growth, 102% net profit growth, ₹20 billion order book
- Indo Farm Equipments
- Manufactures tractors and cranes, 69.53% promoter stake, 10% sales growth, 37% net profit growth, ₹2.6 billion IPO
- Senores Pharma
- Focuses on regulated pharma markets, 45.8% promoter stake, 204% sales growth, 289% net profit growth, 50–60% topline growth guided for FY26
- Suraksha Diagnostic
- Operates diagnostic chain, 48.98% promoter stake, 10% sales growth, 15% net profit growth, ₹8.5 billion IPO